Information pursuant to Section 5 of the German Telemedia Act (Telemediengesetz):
Bundesverband der Arzneimittel-Hersteller e.V.
(German Medicines Manufacturers' Association)
Management Board according to § 26 BGB (German Federal Law Book):
Jörg Wieczorek, Chair, each with one Board member
Dr. Günter Auerbach, Vice-chair
Tobias Boldt, Vice-chair
Dr. Traugott Ullrich, Vice-chair
Erich Nobis, Treasurer
Dorothee Brakmann, PhD
Ralf Mayr-Stein, PhD
Hubertus Cranz, PhD
Register of Associations: Bonn Municipal Court (Amtsgericht Bonn)
Register Number: 4939
Conception, design, web development:
The information contained in this website has been created with utmost diligence and it has been controlled. Liability claims against BAH, relating to damages of material or immaterial kind, which were caused through the use or non-use of the information, are excluded. We reserve the right to change, to supplement or to delete parts of the site or all of the information without separate announcement, or to cease the publication temporarily or permanently.
Through this website, you are able to link to other websites. BAH expressly dissociates from the contents of these sites and does not adopt their contents as its own. We emphasize that we have no control over the content and design of the linked websites. Only the respective supplier of the website, to which reference is made, shall be liable for any damages arising from the use or non-use of the information provided there.
Management board members: © Bettina Volke / BAH; © BAH / Svea Pietschmann
Photo Wieczorek: Hermes Arzneimittel Holding GmbH/Jonas Blaenksen
Photo Dorothee Brakmann, PhD: © Janssen-Cilag GmbH
Photo Stefan Brinkmann: © Merz Pharmaceuticals GmbH
BAH employees: © Johanna Unternährer; © Bettina Volke / BAH; © BAH / Mike Fuchs; © BAH / Svea Pietschmann; @Ralf Bauer; @BILDSCHÖN/Müller
Photo Birgit Ewert, PhD: © Fotostudio Balsereit - Meisterbetrieb für Lichtbildnerei
BAH building: © Jan Schumacher
Graphic Rx-OTC-Switch: BAH
Graphic Justitia: BAH
For reasons of readability, we have waived the simultaneous use of male and female forms of the language. All person terms nevertheless apply to both genders.